✦ LIBER ✦

148 Establishment of PI3K Inhibitor-resistant Cancer Cell Lines and the Therapeutic Strategies for Overcoming the Acquired Resistance

✍ Scribed by Isoyama, S.; Dan, S.; Nishimura, Y.; Kajiwara, G.; Nakamura, N.; Irimura, T.; Yamori, T.

Book ID: 122083228
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 77 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)71946-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishment of phosphatidylinositol 3-

Establishment of phosphatidylinositol 3-kinase inhibitor-resistant cancer cell lines and therapeutic strategies for overcoming the resistance

✍ Isoyama, Sho; Dan, Shingo; Nishimura, Yumiko; Nakamura, Naoki; Kajiwara, Gensei; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

402 Dual Inhibition of the MEK and the P

402 Dual Inhibition of the MEK and the PI3K-Akt-mTOR Pathways Using GSK1120212 (or UO126) and Everolimus Overcomes Resistance to MEK Inhibitors Used as Single Agents in Pancreatic Cancer Cells

✍ Neuzillet, C.; Serova, M.; Raballand, A.; Astorgues-Xerri, L.; Riveiro, M.E.; de 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

370 Identification of IGF1R as a Predict

370 Identification of IGF1R as a Predictive Biomarker for Intrinsic Resistance to PI3K Inhibitors and a Therapeutic Target for Improving the Drug Efficacy

✍ Dan, S.; Isoyama, S.; Nishimura, Y.; Kajiwara, G.; Nakamura, N.; Yamori, T. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Intrinsic resistance to the MEK1/2 inhib

Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines

✍ Kathryn Balmanno; Simon D. Chell; Annette S. Gillings; Shaista Hayat; Simon J. C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 466 KB

## Abstract Mutations in __KRAS__ or __BRAF__ frequently manifest in constitutive activation of the MEK1/2‐ERK1/2 signalling pathway. The MEK1/2‐selective inhibitor, AZD6244 (ARRY‐142886), blocks ERK1/2 activation and is currently undergoing clinical evaluation. Tumour cells can vary markedly in th

W1967 Colon Cancer Cells and Anoikis Res

W1967 Colon Cancer Cells and Anoikis Resistance: EGFR-Dependent Sustained Activation of the SRC-MEK/ERK Pathway Can Override Dependance On FAK, PI3-K/AKT-1 for Survival

✍ Vachon, Pierre H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

823 COMBINED TREATMENT WITH CISPLATIN AN

823 COMBINED TREATMENT WITH CISPLATIN AND DUAL PI3K-MTOR INHIBITOR NVP-BEZ235 CAN RESTORE CASPASE DEPENDENT APOPTOSIS IN CISPLATIN RESISTANT HUMAN BLADDER CANCER CELL THROUGH THE DOWN-REGULATION OF C-FLIP

✍ S.S. Bvun; C.Y. Yoon; M.J. Park; S.W. Doo; H.Z. Park; D.S. Kim; W.K. Lee; S.H. P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 133 KB